![](/img/cover-not-exists.png)
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer
Gallacher, Daniel, Auguste, Peter, Royle, Pamela, Mistry, Hema, Armoiry, XavierLanguage:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-019-00859-5
Date:
October, 2019
File:
PDF, 806 KB
english, 2019